| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.69B | 38.30B | 35.46B | 36.67B | 35.36B | 31.50B |
| Gross Profit | 15.48B | 16.15B | 13.47B | 12.28B | 10.87B | 8.86B |
| EBITDA | 9.35B | 9.61B | 8.85B | 6.77B | 6.51B | 2.63B |
| Net Income | 4.06B | 4.46B | 4.34B | 4.04B | 3.64B | 854.00M |
Balance Sheet | ||||||
| Total Assets | 75.30B | 77.26B | 77.41B | 71.13B | 73.74B | 64.59B |
| Cash, Cash Equivalents and Short-Term Investments | 13.98B | 15.71B | 22.97B | 18.70B | 21.66B | 14.15B |
| Total Debt | 21.36B | 23.02B | 22.91B | 24.06B | 29.32B | 25.37B |
| Total Liabilities | 27.20B | 29.31B | 30.43B | 29.70B | 36.21B | 32.97B |
| Stockholders Equity | 47.96B | 47.76B | 46.74B | 41.26B | 37.43B | 31.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -10.73B | 6.98B | 4.42B | 2.65B | 2.01B |
| Operating Cash Flow | 0.00 | -8.45B | 10.00B | 6.29B | 3.66B | 3.11B |
| Investing Cash Flow | 0.00 | 4.09B | -9.02B | -3.94B | -700.00M | 56.00M |
| Financing Cash Flow | 0.00 | -2.94B | -712.00M | -5.40B | 5.54B | -15.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥16.28B | 15.74 | ― | 1.49% | 1.23% | 0.12% | |
66 Neutral | ¥70.85B | 12.14 | ― | 2.18% | 12.03% | 30.12% | |
65 Neutral | ¥68.22B | 13.68 | ― | 2.88% | 0.02% | -27.38% | |
65 Neutral | ¥36.43B | 18.51 | ― | 2.59% | 4.02% | 18.12% | |
65 Neutral | ¥20.90B | 30.65 | ― | 1.13% | 3.37% | 9.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥6.09B | 19.21 | ― | 2.29% | 0.08% | 105.25% |